Journal Logo

Articles by Masaki Kiga

Antitumor effects of novel highly hydrophilic and non-ATP-competitive MEK1/2 inhibitor, SMK-17

Kiga, Masaki; Tanzawa, Fumie; Iwasaki, Shiho; More

Anti-Cancer Drugs. 23(1):119-130, January 2012.